Generation of allogeneic CAR-T circumvents functional deficits in patientderived autologous product for glioblastoma

被引：0
|
作者：
Shaikh, Muhammad Vaseem
Salim, Sabra K.
Wei, Jeffrey
Maich, William T.
Anand, Alisha A.
Tang, Oliver Young
Subapanditha, Minomi K.
Suk, Yujin
Singh, Manoj
Alizada, Zahra
Brakel, Benjamin
Dimitrov, Vassil
Tabunshchyk, Zoya
Brown, Kevin
Vora, Parvez
Binder, Zev
Venugopal, Chitra
Moffat, Jason
Singh, Sheila K.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5241
引用
收藏
页数：3
相关论文
共 50 条
  • [41] CAR-T Cells: Next Generation Cancer Therapeutics
    Balakrishnan, Ashwini
    JOURNAL OF THE INDIAN INSTITUTE OF SCIENCE, 2018, 98 (01) : 21 - 31
  • [42] Paralleled comparison of vectors for the generation of CAR-T cells
    Qin, Di-Yuan
    Huang, Yong
    Li, Dan
    Wang, Yong-Sheng
    Wang, Wei
    Wei, Yu-Quan
    ANTI-CANCER DRUGS, 2016, 27 (08) : 711 - 722
  • [43] CAR-T Cells: Next Generation Cancer Therapeutics
    Ashwini Balakrishnan
    Journal of the Indian Institute of Science, 2018, 98 : 21 - 31
  • [44] Advanced CAR-T cell against orthotopic glioblastoma mouse model
    Hwang, K.
    Nam, K. M.
    Kwon, J. E.
    Ji, S. Y.
    Han, J. H.
    Seo, T. W.
    Choi, Y. N.
    Kim, K.
    Jeon, S.
    Choi, K.
    Kong, S.
    Kim, C. Y.
    NEURO-ONCOLOGY, 2022, 24
  • [45] CAR-T cells in glioblastoma: towards multi-targeted therapy
    Huebner, J.
    Nickl, V
    AlSalkini, M.
    Grams, B.
    Loehr, M.
    Hudecek, M.
    Nerreter, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 197 - 198
  • [46] Umbilical cord blood: A promising source for allogeneic CAR-T cells
    Liu, Dian-Dian
    Hong, Wei-Cong
    Qiu, Kun-Yin
    Li, Xin-Yu
    Liu, Yong
    Zhu, Li-Wen
    Lai, Wei-Xin
    Chen, Han-
    Yang, Hua-Qing
    Xu, Lu-Hong
    Fang, Jian-Pei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [47] Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?
    Lonez, Caroline
    Breman, Eytan
    CELLS, 2024, 13 (02)
  • [48] DEVELOPMENT OF CRISPR/CAS9-BASED GENOME EDITING PLATFORM FOR THE GENERATION OF ALLOGENEIC CAR-T CELLS
    Lima, S. C. G.
    Brand, H.
    Batista, L. C.
    Fantacini, D. M. C.
    Coelho, M. G. B.
    Castro, F. A.
    Covas, D. T.
    Souza, L. E. B.
    CYTOTHERAPY, 2021, 23 (04) : 10 - 10
  • [49] Evolution of Nutritional Status in Patients Undergoing Autologous and Allogeneic Hematopoietic Cell Transplantation or CAR-T Therapy: A Retrospective Observational Study
    Regazzoni, Roberto
    Ferrante, Sergio
    Morenghi, Emanuela
    Lopane, Diego
    Pastore, Manuela
    Cattani, Daniela
    Cosmai, Simone
    Colotta, Francesco
    Azzolini, Elena
    Sguanci, Marco
    Cangelosi, Giovanni
    Cozzaglio, Luca
    Mazzoleni, Beatrice
    Mancin, Stefano
    CANCERS, 2025, 17 (01)
  • [50] An All-Prime Editing One-Step Approach for Non-Viral Generation of a Multiplex-Edited Allogeneic CAR-T Cell Product
    Pomeroy, Emily J.
    Anzalone, Andrew V.
    Podracky, Christopher J.
    Bloch, Noah B.
    Waterman, David P.
    Chang, Reyna
    Dwivedi, Arika A.
    Laoharawee, Kanut
    Tedeschi, Justin G.
    Macari, Elizabeth R.
    Gori, Jennifer L.
    Duffield, Jeremy S.
    MOLECULAR THERAPY, 2023, 31 (04) : 301 - 302
12345